Silencing LINC00511 inhibits cell proliferation, migration, and epithelial–mesenchymal transition via the PTEN–AKT–FOXO1 signaling pathway in lung cancer

被引：10
作者：
Jiang L. [1 ]
Xie X. [1 ]
Ding F. [1 ]
Mei J. [1 ]
Bi R. [1 ]
机构：
[1] Department of Cardiothoracic Surgery, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai
来源：
Biochemistry and Cell Biology | 2021年 / 99卷 / 02期
基金：
中国国家自然科学基金;
关键词：
EMT; FOXO1; LINC00511; lung cancer; migration; PTEN;
D O I：
10.1139/bcb-2018-0364
中图分类号：
学科分类号：
摘要：
Lung cancer is the most common cause of cancer-related death worldwide. Long noncoding RNAs (lncRNAs) are longer than 200 nt transcripts and are not translated into proteins. Increasing evidence has shown that lncRNAs are associated with several biological processes in cancer. However, the roles of LINC00511 in lung cancer progression remain unknown. In the present study, we confirmed that LINC00511 knockdown significantly inhibited cell proliferation and migration in A549, SPCA1, and H460 cells. Western blot results showed that silencing LINC00511 inhibited epithelial– mesenchymal transition (EMT), which resulted in decreased expression levels of ZEB2, N-cadherin, and vimentin and increased expression levels of E-cadherin. Additionally, silencing LINC00511 significantly upregulated PTEN mRNA and protein expression, increased FOXO1, and inactivated AKT. Furthermore, we found that PTEN knockdown reversed the inhibition of cell migration and proliferation induced by LINC00511 siRNA, markedly reduced p-FOXO1 expression, and promoted p-AKT expression and EMT in A549 and H460 cells. Therefore, these findings revealed that LINC00511 functions as an oncogene through the PTEN–AKT–FOXO1 signaling pathway in lung cancer, providing a potential target of metastasis in lung cancer. © 2021, Canadian Science Publishing. All rights reserved.
引用
收藏
页码：1 / 8
页数：7
相关论文
共 36 条
  • [1] Arun G., Diermeier S.D., Spector D.L., Therapeutic Targeting of Long Non-Coding RNAs in Cancer, Trends Mol. Med., 24, 3, pp. 257-277, (2018)
  • [2] Cabanski C.R., White N.M., Dang H.X., Silva-Fisher J.M., Rauck C.E., Cicka D., Maher C.A., Pan-cancer transcriptome analysis reveals long non-coding RNAs with conserved function, RNA Biol, 12, 6, pp. 628-642, (2015)
  • [3] Chen P., Fang X., Xia B., Zhao Y., Li Q., Wu X., Long noncoding RNA LINC00152 promotes cell proliferation through competitively binding endogenous miR-125b with MCL-1 by regulating mitochondrial apoptosis pathways in ovarian cancer, Cancer Med, 7, 9, pp. 4530-4541, (2018)
  • [4] Chen S., Wu H., Lv N., Wang H., Wang Y., Tang Q., Et al., LncRNA CCAT2 predicts poor prognosis and regulates growth and metastasis in small cell lung cancer, Biomed. Pharmacother., 82, pp. 583-588, (2016)
  • [5] Comijn J., Berx G., Vermassen P., Verschueren K., van Grunsven L., Bruyneel E., Et al., The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion, Mol. Cell, 7, 6, pp. 1267-1278, (2001)
  • [6] Ding J., Yang C., Yang S., LINC00511 interacts with miR-765 and modulates tongue squamous cell carcinoma progression by targeting LAMC2, J. Oral Pathol. Med., 47, 5, pp. 468-476, (2018)
  • [7] Dong T., Zhang Y., Chen Y., Liu P., An T., Zhang J., Et al., FOXO1 inhibits the invasion and metastasis of hepatocellular carcinoma by reversing ZEB2-induced epithelial–mesenchymal transition, Oncotarget, 8, 1, pp. 1703-1713, (2017)
  • [8] Doyle S.E., Scholz M.J., Greer K.A., Hubbard A.D., Darnell D.K., Antin P.B., Et al., Latrophilin-2 is a novel component of the epithelial-mesenchymal transition within the atrioventricular canal of the embryonic chicken heart, Dev. Dyn., 235, 12, pp. 3213-3221, (2006)
  • [9] Duan X., Fu Z., Gao L., Zhou J., Deng X., Luo X., Et al., Direct interaction between miR-203 and ZEB2 suppresses epithelial-mesenchymal transition signaling and reduces lung adenocarcinoma chemoresistance, Acta Biochim. Biophys. Sin., 48, 11, pp. 1042-1049, (2016)
  • [10] Gutschner T., Hammerle M., Eissmann M., Hsu J., Kim Y., Hung G., Et al., The noncoding RNA MALAT1 is a critical regulator of the metastasis pheno-type of lung cancer cells, Cancer Res, 73, 3, pp. 1180-1189, (2013)
1234